| Title: | Multi-omics and Mendelian randomization study explores potential therapeutic targets for meningiomas |
| Journal: | Discover Oncology |
| Published: | 2 Aug 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40751857/ |
| DOI: | https://doi.org/10.1007/s12672-025-03318-0 |
| URL: | https://link.springer.com/content/pdf/10.1007/s12672-025-03318-0.pdf |
Publication 17468
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundMeningioma is a common primary central nervous system tumor that can cause a heavy burden on patients. Despite its well-established treatment modalities, pharmacological treatments are not sufficiently abundant. Therefore, we explored potential therapeutic targets for meningiomas by integrating genomic and proteomic data.MethodsWe integrated meningioma data from the UK Biobank and Finnish databases and subsequently explored potential therapeutic targets for meningiomas through multi-omics data using bioinformatics techniques and Mendelian randomization. These targets were finally evaluated using phenotype-wide association group analysis.ResultsWe found that BET1L, COL17A1, CFAP43, SH3PXD2A, TTC28, ZNRF3, SLK, AKR1C3, NRXN3, and RSPO3 can be potential therapeutic targets for meningiomas.ConclusionThis study provides evidence and explores the biological significance of BET1L, COL17A1, CFAP43, SH3PXD2A, TTC28, ZNRF3, SLK, AKR1C3, NRXN3, and RSPO3 as potential therapeutic targets for meningiomas, providing new insights into the development of targeted therapy for meningiomas.Graphical abstract</p>
6 Authors
- Yongxue Li
- Lihao Lin
- Wenhui Zhang
- Yan Wang
- Haoyu Shen
- Yi Guan
Enabling scientific discoveries that improve human health